相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
Guillaume P. Andrieu et al.
MOLECULAR CANCER RESEARCH (2018)
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
Fred C. Lam et al.
NATURE COMMUNICATIONS (2018)
Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts
Yuankun Zhai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling
Huan-Tian Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma
Victoria M. Wu et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
In silico design and bioevaluation of selective benzotriazepine BRD4 inhibitors with potent antiosteoclastogenic activity
Vishwa Deepak et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis
Marc Baud'huin et al.
BONE (2017)
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma
Tim Hensel et al.
ONCOTARGET (2016)
Bromodomains: Structure, function and pharmacology of inhibition
Elena Ferri et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth
Ningning Niu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Hemant K. Bid et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure
J. D. Hald et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
Camille Jacques et al.
ONCOTARGET (2016)
BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma
Sudan N. Loganathan et al.
ONCOTARGET (2016)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis
Bebeka Gjoksi et al.
BONE (2015)
Coamplification of Myc/Pvt1 and Homozygous Deletion of Nlrp1 Locus are Frequent Genetics Changes in Mouse Osteosarcoma
Pulivarthi H. Rao et al.
GENES CHROMOSOMES & CANCER (2015)
The Indications and Efficacy of Conventional Chemotherapy in Primary and Recurrent Sarcoma
David A. Liebner
JOURNAL OF SURGICAL ONCOLOGY (2015)
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
Madhusoodanan Mottamal et al.
MOLECULES (2015)
Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7
Zhen Xue et al.
PLOS ONE (2015)
Targeting BET bromodomains for cancer treatment
Marie Jung et al.
EPIGENOMICS (2015)
A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
Lisa Mirabello et al.
CANCER DISCOVERY (2015)
BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
Emma K. Baker et al.
SCIENTIFIC REPORTS (2015)
Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma
Dhong Hyun Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali et al.
ANNALS OF ONCOLOGY (2014)
The bromodomain: From epigenome reader to druggable target
Roberto Sanchez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
Jian Shi et al.
CANCER CELL (2014)
Histone variants: key players of chromatin
Burcu Biterge et al.
CELL AND TISSUE RESEARCH (2014)
An epigenomic approach to therapy for tamoxifen-resistant breast cancer
Qin Feng et al.
CELL RESEARCH (2014)
A mechanistic link between gene regulation and genome architecture in mammalian development
Giancarlo Bonora et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction
S. Meng et al.
JOURNAL OF DENTAL RESEARCH (2014)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
Li-Fraumeni syndrome: cancer risk assessment and clinical management
Kate A. McBride et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
Z. Zou et al.
ONCOGENE (2014)
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
Jennifer A. Perry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response
M. Hussong et al.
CELL DEATH & DISEASE (2014)
Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation
Kyung-Hyun Park-Min et al.
NATURE COMMUNICATIONS (2014)
Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle
Francois Lamoureux et al.
NATURE COMMUNICATIONS (2014)
Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma
Kaishun Hu et al.
ONCOTARGET (2014)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen et al.
CELL REPORTS (2014)
BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
Miguel F. Segura et al.
CANCER RESEARCH (2013)
Stable Pausing by RNA Polymerase II Provides an Opportunity to Target and Integrate Regulatory Signals
Telmo Henriques et al.
MOLECULAR CELL (2013)
Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
Shwu-Yuan Wu et al.
MOLECULAR CELL (2013)
The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
Scott R. Floyd et al.
NATURE (2013)
Genome-wide association study identifies two susceptibility loci for osteosarcoma
Sharon A. Savage et al.
NATURE GENETICS (2013)
FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
Laura Christensen et al.
PLOS ONE (2013)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
The Epigenotype
C. H. Waddington
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B
Pablo Garcia-Gutierrez et al.
JOURNAL OF CELL SCIENCE (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms
Diana C. Hargreaves et al.
CELL RESEARCH (2011)
A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in Cardiomyocytes
Jagat C. Borah et al.
CHEMISTRY & BIOLOGY (2011)
The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
Shaila Rahman et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes
Janine M. Lamonica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines
Yi Zhang et al.
ONCOLOGY LETTERS (2011)
The TIF1 alpha-related TRIM cofactors couple chromatin modifications to transcriptional regulation, signaling and tumor suppression
Benjamin Herquel et al.
TRANSCRIPTION-AUSTIN (2011)
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells
Liu Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The molecular pathogenesis of Ewing sarcoma
Carlos Mackintosh et al.
CANCER BIOLOGY & THERAPY (2010)
Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2
Zachary Charlop-Powers et al.
CELL RESEARCH (2010)
Osteopetrosis due to Homozygous Chloride Channel ClCN7 Mutation Mimicking Metabolic Disease with Haematological and Neurological Impairment
D. Furthner et al.
KLINISCHE PADIATRIE (2010)
Downstream EWS/FLI1-upstream Ewing's sarcoma
Heinrich Kovar
GENOME MEDICINE (2010)
The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis
Aron Gyuris et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2
Alexander B. Mohseny et al.
JOURNAL OF PATHOLOGY (2009)
Cooperative binding of two acetylation marks on a histone tail by a single bromodomain
Jeanne Moriniere et al.
NATURE (2009)
A Molecular Function Map of Ewing's Sarcoma
Maximilian Kauer et al.
PLOS ONE (2009)
Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades - Surveillance Epidemiology and End Results data
Natia Esiashvili et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells
E. Garcia-Aragoncillo et al.
ONCOGENE (2008)
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
J. P. Zwerner et al.
ONCOGENE (2008)
Mammalian ASH1L is a histone methyl transferase that occupies the transcribed region of active genes
Gregory D. Gregory et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Ewing's sarcoma family of tumors: Current management
Mark Bernstein et al.
ONCOLOGIST (2006)
Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function
MR Schweiger et al.
JOURNAL OF VIROLOGY (2006)
Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: Preservation of acetylated chromatin
A Nishiyama et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
EWS-ETS oncoproteins: The linchpins of Ewing tumors
R Janknecht
GENE (2005)
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells
N Riggi et al.
CANCER RESEARCH (2005)
Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment
JVMG Bovée et al.
LANCET ONCOLOGY (2005)
Histone acetylation and deacetylation: importance in inflammatory lung diseases
PJ Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Biology and therapeutic advances for pediatric osteosarcoma
N Marina et al.
ONCOLOGIST (2004)
Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins, c-Jun and p300
B Fuchs et al.
FEBS LETTERS (2003)
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors
AA Sandberg et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Bromodomains mediate an acetyl-histone encoded antisilencing function at heterochromatin boundaries
AG Ladurner et al.
MOLECULAR CELL (2003)
Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4
D Houzelstein et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Histone H2A variants H2AX and H2AZ
C Redon et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase Gcn5p
DJ Owen et al.
EMBO JOURNAL (2000)
SMART: a web-based tool for the study of genetically mobile domains
J Schultz et al.
NUCLEIC ACIDS RESEARCH (2000)
HATs off: Selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF
OD Lau et al.
MOLECULAR CELL (2000)
分享论文
